| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.22B | 42.90B | 40.02B | 32.27B | 21.13B | 18.30B |
| Gross Profit | 5.26B | 4.33B | 3.03B | 979.00M | -4.27B | -8.86B |
| EBITDA | 3.11B | 1.80B | 701.00M | -672.00M | -5.50B | -9.48B |
| Net Income | 2.62B | 1.92B | 912.00M | 73.00M | -4.99B | -10.07B |
Balance Sheet | ||||||
| Total Assets | 24.82B | 24.56B | 23.82B | 21.57B | 20.09B | 32.77B |
| Cash, Cash Equivalents and Short-Term Investments | 11.63B | 10.81B | 8.65B | 6.14B | 6.44B | 16.06B |
| Total Debt | 2.95B | 3.13B | 5.78B | 3.58B | 4.93B | 10.90B |
| Total Liabilities | 20.53B | 20.27B | 20.60B | 19.80B | 18.73B | 26.49B |
| Stockholders Equity | 4.29B | 4.29B | 3.22B | 1.76B | 1.36B | 6.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.16B | 409.00M | 64.00M | -5.25B | -3.82B |
| Operating Cash Flow | 0.00 | 5.27B | 529.00M | 122.00M | -5.23B | -3.72B |
| Investing Cash Flow | 0.00 | -427.00M | -267.00M | -159.00M | 1.07B | 520.00M |
| Financing Cash Flow | 0.00 | -2.65B | 2.17B | -356.00M | -5.72B | 9.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥8.54B | 1.31 | ― | 1.67% | 2.08% | 48.38% | |
73 Outperform | ¥1.37T | 5.50 | ― | 1.97% | 9.28% | 2.58% | |
72 Outperform | ¥7.98B | 7.03 | ― | 0.47% | 3.15% | 4.75% | |
71 Outperform | ¥1.14T | 6.85 | 11.50% | 3.11% | 11.16% | 49.16% | |
66 Neutral | ¥7.68B | 194.86 | ― | ― | 3.80% | -59.73% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |